OFI INVEST ASSET MANAGEMENT
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1977602
ISSY LES MOULINEAUX, I0
Position in ALNY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$11,422,583
+$11,181,379 QoQ
Shares Held
37,945
+5105.1% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#176
of 785 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OFI INVEST ASSET MANAGEMENT holds $64,308,324 across 6 Biotechnology names. ALNY ranks #2 (17.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
547,881 | $38,368,106 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
37,945 | $11,422,583 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,449 | $5,190,331 | |
| 4 | INSM |
INSMED Inc
|
47,000 | $5,011,140 | |
| 5 | INCY |
Incyte Corp
|
37,762 | $4,280,700 | |
| 6 | LEGN |
Legend Biotech Corp
|
1,228 | $35,464 |
All Filings in ALNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,422,583 | 37,945 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $241,204 | 729 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $308,576 | 776 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $183,768 | 403 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $124,240 | 381 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $81,546 | 302 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $36,473 | 155 | Shares | Sole | 2025-02-07 | |
| 2023-12-31 | $27,371 | 143 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||